|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2005-10-31
|
|
pubmed:abstractText |
Given the role of nutrition and body weight gain in normal development, pharmaceuticals intended to reduce appetite and promote weight loss will generate safety data that may be challenging to interpret. To aid with this, the effects of feed restriction and subsequent body weight reductions on embryo-fetal development were investigated in the rat.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1542-9733
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2005 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
74
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
442-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16193501-Animal Feed,
pubmed-meshheading:16193501-Animals,
pubmed-meshheading:16193501-Body Weight,
pubmed-meshheading:16193501-Bone and Bones,
pubmed-meshheading:16193501-Embryo, Mammalian,
pubmed-meshheading:16193501-Embryonic Development,
pubmed-meshheading:16193501-Female,
pubmed-meshheading:16193501-Fetal Development,
pubmed-meshheading:16193501-Fetal Weight,
pubmed-meshheading:16193501-Food Deprivation,
pubmed-meshheading:16193501-Organ Size,
pubmed-meshheading:16193501-Organogenesis,
pubmed-meshheading:16193501-Pregnancy,
pubmed-meshheading:16193501-Rats,
pubmed-meshheading:16193501-Rats, Sprague-Dawley
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
The effects of feed restriction during organogenesis on embryo-fetal development in the rat.
|
|
pubmed:affiliation |
Pfizer Global Research and Development, Groton, Connecticut 06340, USA. tammye.l.fleeman@pfizer.com
|
|
pubmed:publicationType |
Journal Article
|
